| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
- |
| Employees |
50 |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-6 |
| Cash Flow (TTM) (Millions $) |
-1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Intellipharmaceutics International Inc is a pharmaceutical company based in Toronto, Canada. The company focuses on the development and commercialization of novel and generic controlled-release and targeted-release oral solid dosage drugs.
Intellipharmaceutics utilizes its proprietary drug delivery technologies to enhance the therapeutic value of existing drugs while minimizing side effects. Their drug delivery systems include features like controlled release, abuse deterrence, and improved safety profiles.
The company's product pipeline includes various drug candidates targeting conditions such as ADHD, opioid misuse, epilepsy, and depression. In addition to developing their own products, Intellipharmaceutics also partners with pharmaceutical companies for the development and commercialization of select products.
Intellipharmaceutics has a strong focus on research and development, with a team of scientists and researchers dedicated to advancing their drug delivery technologies and expanding their product portfolio. Overall, the company aims to improve patient outcomes by providing innovative and effective drug delivery solutions.
Company Address: 30 Worcester Road Toronto 0 ON
Company Phone Number: Stock Exchange / Ticker: IPCIF
|
%
